Eli Lilly rises 1.9% to $1,268.23 on strong obesity drug demand
LLY Lilly(Eli) & Co
$1255.40 +0.88%
View chart & analysis → - 1Eli Lilly (LLY) traded at $1,268.23 on Friday afternoon, up about 1.9%
- 2Second-quarter revenue jumped 48% to $23 billion, and the company raised its full-year guidance to $85–87 billion
- 3Mounjaro and Zepbound accounted for roughly 65% of quarterly revenue, prompting Wall Street to buy the stock on its growth potential
This 3-line summary is compiled from the report below.
Investor's Business Daily +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다